Unlock regulatory insights with Watson. Learn More
Return to Docket

Declare That the Drug Product, Primidone Capsules, 50mg, 100 mg, 125 mg, is Suitable for Consideration in an Abbreviated New Drug Application (ANDA)-CLOSED

Type: Non-Rule Making
KeyWord(s) primidone capsules, 50 mg 100 mg 125 mg 250 mg, mysoline, CDER, closed
Short title Declare That the Drug Product, Primidone Capsules, 50mg, 100 mg, 125 mg, is Suitable for Consideration in an Abbreviated New Drug Application (ANDA)
Docket Item Code P
Center CDER

0 Comments

Click here to view all comments of this document.